{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:38:02Z","timestamp":1793813882358,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtct.2026.01.029","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:15:22Z","timestamp":1769616922000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Allogeneic Hematopoietic Cell Transplantation for Morquio A Syndrome: An International Retrospective Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6014-7659","authenticated-orcid":false,"given":"Sandhya","family":"Kharbanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-9870","authenticated-orcid":false,"given":"Koray","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Yesilipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-5496","authenticated-orcid":false,"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Alghasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-1632","authenticated-orcid":false,"given":"Nikki","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-9936","authenticated-orcid":false,"given":"Rajat","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-8818","authenticated-orcid":false,"given":"Irtiza","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-4347","authenticated-orcid":false,"given":"Gregory M.T.","family":"Guilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Grimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-3952","authenticated-orcid":false,"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.01.029_bib0001","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0002","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.029_bib0003","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4103\/neurol-india.Neurol-India-D-24-00312","article-title":"A complete clinical spectrum of Morquio syndrome","volume":"72","author":"Bansal","year":"2024","journal-title":"Neurol India"},{"issue":"01","key":"10.1016\/j.jtct.2026.01.029_bib0004","first-page":"141","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","article-title":"The Morquio A clinical assessment program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects","volume":"109","author":"Harmatz","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtct.2026.01.029_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-9-32","article-title":"Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey","volume":"9","author":"Hendriksz","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2026.01.029_bib0007","first-page":"59","article-title":"Natural history of Morquio A patient with tracheal obstruction from birth to death","volume":"14","author":"Doherty","year":"2018","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-013-9586-2","article-title":"Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management","volume":"36","author":"Solanki","year":"2013","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.029_bib0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","article-title":"Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder","volume":"109","author":"Yasuda","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.36833","article-title":"International guidelines for the management and treatment of Morquio A syndrome","volume":"167A","author":"Hendriksz","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.029_bib0011","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/21678707.2016.1214572","article-title":"Current therapies for Morquio A syndrome and their clinical outcomes","volume":"4","author":"Sawamoto","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.029_bib0012","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1080\/17512433.2017.1260000","article-title":"Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A syndrome)","volume":"9","author":"Hendriksz","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jtct.2026.01.029_bib0013","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/DDDT.S68562","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome","volume":"9","author":"Tomatsu","year":"2015","journal-title":"Drug Des Devel Ther,"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.029_bib0014","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","article-title":"Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations","volume":"3","author":"Tomatsu","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.029_bib0016","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40262-014-0173-y","article-title":"Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome","volume":"53","author":"Qi","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0017","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0018","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2012","author":"Tomatsu","year":"2012","journal-title":"Res Rep Endocr Disord"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.029_bib0019","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s10038-019-0604-6","article-title":"Effect of enzyme replacement therapy on the growth of patients with Morquio A","volume":"64","author":"Doherty","year":"2019","journal-title":"J Hum Genet"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0020","article-title":"Long-term outcomes of early enzyme replacement therapy for mucopolysaccharidosis IV: clinical case studies of two siblings","volume":"10","author":"Barak","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jtct.2026.01.029_bib0021","first-page":"42","article-title":"30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: about one case","volume":"9","author":"Do Cao","year":"2016","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0022","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2016.04.005","article-title":"Activity of daily living for Morquio A syndrome","volume":"118","author":"Yasuda","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtct.2026.01.029_bib0023","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"1-2","key":"10.1016\/j.jtct.2026.01.029_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis","volume":"125","author":"Khan","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinthera.2016.11.017","article-title":"Long-term Immunogenicity of elosulfase alfa in the treatment of Morquio A syndrome: results from MOR-005, a phase III extension study","volume":"39","author":"Long","year":"2017","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.029_bib0026","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinthera.2014.11.005","article-title":"Immunogenicity of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome: results from MOR-004, a phase III trial","volume":"37","author":"Schweighardt","year":"2015","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41409-024-02439-4","article-title":"Hematopoietic stem cell transplantation in children with mucopolysaccharidosis IVA: single center experience","volume":"60","author":"Yalcin","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.01.029_bib0029","first-page":"31","article-title":"Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA","volume":"1","author":"Chinen","year":"2014","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0030","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"10.1016\/j.jtct.2026.01.029_bib0031","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/bbmt.2003.50000","article-title":"A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections","volume":"9","author":"Anderson","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.029_bib0033","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bmt.1704127","article-title":"Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study","volume":"32","author":"Heldal","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.01.029_bib0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-031-84988-6_4","article-title":"Graft source choice","volume":"1475","author":"Hong","year":"2025","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.029_bib0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjh.16107","article-title":"Current status of umbilical cord blood transplantation in children","volume":"190","author":"Gabelli","year":"2020","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.jtct.2026.01.029_bib0036","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/bloodadvances.2020003824","article-title":"Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses","volume":"5","author":"van den Broek","year":"2021","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.jtct.2026.01.029_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cells13181524","article-title":"Current approaches for the prevention and treatment of acute and chronic GVHD","volume":"13","author":"Olivieri","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.029_bib0038","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0039","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2017.5","article-title":"Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome","volume":"52","author":"Lum","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.029_bib0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bmt.2016.356","article-title":"Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature","volume":"52","author":"Mallhi","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.029_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112462","article-title":"Prospective validation and refinement of a population pharmacokinetic model of fludarabine in children and young adults undergoing hematopoietic cell transplantation","volume":"14","author":"Brooks","year":"2022","journal-title":"Pharmaceutics"},{"issue":"23","key":"10.1016\/j.jtct.2026.01.029_bib0042","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1182\/bloodadvances.2024012670","article-title":"Effect of rabbit ATG PK on outcomes after TCR-alphabeta\/CD19-depleted pediatric haploidentical HCT for hematologic malignancy","volume":"8","author":"Dvorak","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.029_bib0043","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.bbmt.2017.06.021","article-title":"Pharmacokinetics and model-based dosing to optimize fludarabine therapy in pediatric hematopoietic cell transplant recipients","volume":"23","author":"Ivaturi","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1016\/j.jtct.2026.01.029_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165634","article-title":"Lower exposure to busulfan allows for stable engraftment of donor hematopoietic stem cells in children with mucopolysaccharidosis type I: a case report of four patients","volume":"21","author":"Shukla","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.029_bib0045","doi-asserted-by":"crossref","first-page":"690.e1","DOI":"10.1016\/j.jtct.2024.04.006","article-title":"Diagnosing and grading of sinusoidal obstructive syndrome after hematopoietic stem cell transplant of children, adolescent and young adults treated in a pediatric institution with pediatric protocols","volume":"30","author":"Salinas Cisneros","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.029_bib0046","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.029_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061637","article-title":"Improved clinical outcomes of high risk beta thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts","volume":"8","author":"Mathews","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.029_bib0048","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.029_bib0049","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10545-017-0034-6","article-title":"Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation","volume":"40","author":"Lum","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0050","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.029_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12081338","article-title":"Efficacy of intravenous elosulfase alfa for mucopolysaccharidosis Type IVA: a systematic review and meta-analysis","volume":"12","author":"Lee","year":"2022","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.029_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030989","article-title":"A case report of a Japanese Boy with Morquio A syndrome: effects of enzyme replacement therapy initiated at the age of 24 months","volume":"21","author":"Nakamura-Utsunomiya","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.jtct.2026.01.029_bib0053","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJM195604052541402","article-title":"Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children","volume":"254","author":"Blodgett","year":"1956","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.029_bib0054","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","article-title":"Long-term linear growth of children with severe steroid-responsive nephrotic syndrome","volume":"18","author":"Emma","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/adc.2007.129957","article-title":"Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome","volume":"95","author":"Simmonds","year":"2010","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.029_bib0056","first-page":"1296","article-title":"Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with long term glucocorticoids","volume":"29","author":"Simon","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2026.01.029_bib0057","article-title":"Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA","volume":"31","author":"Lee","year":"2022","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0058","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Montano","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.029_bib0059","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2014.10.015","article-title":"Longitudinal analysis of endurance and respiratory function from a natural history study of Morquio A syndrome","volume":"114","author":"Harmatz","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13023-019-1105-6","article-title":"Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study","volume":"14","author":"Leong","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"17","key":"10.1016\/j.jtct.2026.01.029_bib0061","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1111\/j.1742-4658.2010.07769.x","article-title":"Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1","volume":"277","author":"Almeciga-Diaz","year":"2010","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.029_bib0062","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1038\/s41467-021-25697-y","article-title":"Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy","volume":"12","author":"Bertolin","year":"2021","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1016\/j.jtct.2026.10.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:00:00Z","timestamp":1793750400000}}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:08:50Z","timestamp":1776856130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S2666636726000631"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.029","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Hematopoietic Cell Transplantation for Morquio A Syndrome: An International Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}